Pharmacokinetics of Low-Dose Methotrexate in Rheumatoid Arthritis Patients
- 1 February 1989
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 78 (2), 165-171
- https://doi.org/10.1002/jps.2600780219
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritisArthritis & Rheumatism, 1986
- High-performance liquid chromatographic assay for methotrexate utilizing a cold acetonitrile purification and separation of plasma or cerebrospinal fluidJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Weekly Pulse Methotrexate in Rheumatoid ArthritisAnnals of Internal Medicine, 1985
- Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical TrialArthritis & Rheumatism, 1985
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Low dose oral methotrexate in rheumatoid arthritis: An uncontrolled trial and review of the literatureSeminars in Arthritis and Rheumatism, 1983
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- A rapid, radiochemical-ligand binding assay for methotrexateAnalytical Biochemistry, 1976
- Comparison of serum concentrations of methotrexate after various routes of administrationCancer, 1975
- Pharmacokinetics of methotrexateClinical Pharmacology & Therapeutics, 1973